Latest news, reports, and more from the RedChip Nation.
 
Discovering Tomorrow's Blue Chips Today
May 26, 2021     Contact    
Featured This Week
 
Annovis Bio Raises $50M on Positive Phase 2 Data in Alzheimer’s and Parkinson’s
 

 


Annovis Bio (NYSE American: ANVS), which was first featured here in February 2020, was one of the most heavily traded stocks across US markets last Friday on a report of positive data from the Company’s Phase 2a trial in Alzheimer’s patients. This came just days after Annovis reported positive data from the Parkinson’s arm of the same study.

The combination of positive data led to shares trading nearly 300% higher at their peak on Friday, with the stock ending the day up more than 100% on more than 39 million shares. Institutional investors jumped on board over the weekend, giving the company $50 million in new capital at $50 a share.

Additional interim data are expected in the coming months, with final data readouts anticipated by year-end. Annovis is already planning to launch a Phase 3 trial in Alzheimer’s in persons with Down Syndrome and filed for Orphan Drug Designation with the US FDA earlier in May.

Despite being up around 1,000% from where we first introduced it to our subscribers, Annovis still trades for only a fraction of the valuation of its peers. It has the potential to trade several times higher just to reach alignment with its peers, and if it continues to generate positive data as its development programs move forward, and reaches eventual approval, it could ultimately be a multi-billion-dollar blockbuster.


Learn more at www.annovisbio.com.

 
 >
Latest News
 
Annovis Bio (NYSE American: ANVS) Announces Positive Phase 2 Data - ANVS401 Improves Cognition in Alzheimer's Disease - Patients' Cognition Improved 3.3 Points on ADAS-Cog11
 >
Annovis Bio (NYSE American: ANVS) Announces Positive Phase 2 Data: ANVS401 Significantly Lowers Inflammatory Markers in Parkinson's Patients
 >
Annovis Bio (NYSE American: ANVS) Appoints Accomplished Neuroscientist, Dr. Cheng Fang as VP of Research
 
 
Nano Dimension (NASDAQ: NNDM) Announces Sale of DragonFly LDM® to a Leading University in Quebec, Canada
 
 
Nano Dimension (NASDAQ: NNDM) Reports 2021 First Quarter Financial Results with CEO Letter to Shareholders
 
 
Kiromic (NASDAQ: KRBP) Announces FDA IND Submission Forty-Five Days before the end of the Second Quarter: First-In-Human, Off-The-Shelf Chimeric PD1 Switch Receptor - Gamma Delta T-cell Therapy
 
 
Kiromic (NASDAQ: KRBP) Announces Identification of Novel Targets for Allogeneic CAR Gamma Delta T-cell Therapy in Solid Tumors Utilizing Kiromic's Proprietary Artificial Intelligence Engine
 
 
Recruiter.com (OTCQB: RCRT) Reports First Quarter 2021 Results, QoQ Sales Up 39 Percent
 
 
Esports Entertainment Group (NASDAQ: GMBL) Reports Fiscal 2021 Third Quarter Financial Results
 
 
EVmo (OTCQB: YAYO) Announces First Quarter 2021 Results with Record Revenue of $2.3M
 
 
DeFi Technologies' (OTC: DEFTF) Wholly Owned Subsidiary, Valour Structured Products, Announces a Record First Trading Day of its Newly Launched Cardano ETP with over $110M SEK traded
 
 
Integrated Launcher Solutions Finalizes Definitive Agreement with Draganfly (OTCQB: DFLY) to Develop Drone-Based Non-Lethal Air Support Defense System
 
 
Medalist Diversified REIT (NASDAQ: MDRR) Announces the Purchase of Lancer Center
 
 
Medalist Diversified REIT (NASDAQ: MDRR) Announces Extension of Clemson University Rental Agreement Through May 2022 for Its Clemson Best Western Property
 
 
Milestone Scientific (NYSE American: MLSS) Reports a 61% Increase in Revenue for Q1 2021
 
 
Vision Marine Technologies (NASDAQ: VMAR) Announces Contract with The Limestone Boat Company to supply its E-Motion Powertrain Technology
 
 
SPI Energy’s (NASDAQ: SPI) Phoenix Motorcars Named to Fast Company's Annual List of World Changing Ideas for 2021
 
 
SPI Energy’s (NASDAQ: SPI) SolarJuice Appoints 24-Year Finance Industry Veteran as CFO
 
 
DSS (NYSE American: DSS) Launches DSS PureAir, Inc. and Makes Investment into Innovative Proactive Air and Surface Purification Solutions Technology from Puradigm LLC
 
 
iMetal Resources (OTC: ADTFF) Announces Equity Financing to Fund Development of Projects
 
 
Killi (OTCQB: MYIDF) Files Information Circular For Annual & Special Meeting of Shareholders
 
 
CBD of Denver’s (OTC: CBDD) CEO Provides Letter to Shareholders Updating Latest Corporate Developments
 
 
CBD of Denver (OTC: CBDD) Further Improves Investor Transparency with New Investors Area on Corporate Website
 
 
 
Upcoming Zoom Webinar
 

Join Zoom Meeting: zoom.us/j/91961935543
One tap mobile : US:
+16465588656,,91961935543#,,,,*777467#
or +13017158592,,91961935543#,,,,*777467#
Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 919 6193 5543
Passcode: 777467
International numbers available:
zoom.us/u/abtNO44aGn


 
 
 
 
 

Join Zoom Meeting: zoom.us/j/95528470314
Or iPhone one-tap : US: +13017158592,,95528470314#,,,,*279079# or +13126266799,,95528470314#,,,,*279079#
Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 955 2847 0314
Passcode: 279079
International numbers available:
zoom.us/u/adoStA3Dei


 
 
 
 

Join Zoom Meeting: zoom.us/j/96144751761
Or iPhone one-tap : US: +13017158592,,96144751761#,,,,*527721#
or +13126266799,,96144751761#,,,,*527721#
Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 961 4475 1761
Passcode: 527721
International numbers available:
zoom.us/u/aep2wunPC3


 
 
 
 
 
 
 
Quote of the Week
 
"The single most important way we attempt to manage risk, in any environment, is by seeking to buy stocks very cheaply—we never want to pay too much."
- Bill Hench, Portfolio Manager, Royce Opportunity Funds
 
 
 
Lesson of the Week
 
The challenge of using technical analysis with smaller-cap stocks.
Read More
 
 
 

 

Latest Videos
 
 
This Week on RedChip TV: Two Under-the-Radar Stocks with Significant Upside Potential
 
This week’s episode of the RedChip Money Report features interviews with executives from Palisade Bio (NASDAQ: PALI), and American Resources (NASDAQ: AREC). Visit RedChip.com to learn more.
 
Watch Now
 
 
 
 
American Resources: Raw Materials for the New Infrastructure Market
 
American Resources Corp. (Nasdaq: AREC) is a next-generation, environmentally and socially responsible supplier of high-quality raw materials to the new infrastructure market. The Company is focused on the extraction and processing of metallurgical carbon, an essential ingredient used in steelmaking, critical rare earth minerals for the electrification market, and reprocessed metal to be recycled.
 
Watch Now
 
 
 
 
Genetic Technologies: Expanding Portfolio of Disease Risk Tests
 
Genetic Technologies (Nasdaq: GENE) is a diversified molecular diagnostics company developing tools for the prediction and assessment of cancer risk to help physicians proactively manage patient health. The Company’s lead products, ‘GeneType for Breast Cancer’ and ‘GeneType for Colorectal Cancer’, are clinically validated risk assessment tests that are first in their class.
 
Watch Now
 
 
 
 
Milestone Scientific: Leading Injection Technology Innovator
 
Milestone Scientific (NYSE American: MLSS) is a leading medical research and development company that designs and patents innovative injection technology. The Company’s clinically validated, patented, computer-controlled systems make injections precise, efficient, and virtually painless, addressing unmet needs and providing a potential new standard of care in anesthesia.
 
Watch Now
 
 
 
 
iMetal Resources: Exploring for Gold in Eastern Canada
 
iMetal Resources (OTC: ADTFF) is a Canadian based junior exploration company focused on the exploration and development of its portfolio of resource properties in Ontario and Quebec. iMetal is focused on advancing its Gowganda West Project that borders Caldas Gold Corp’s 2.2 million ounce Juby Project, an advanced exploration-stage gold project located within the Shining Tree area in the southern part of the Abitibi greenstone belt about 100 km south-southeast of the Timmins gold camp.
 
Watch Now
 
 
 
 
Palisade Bio: Phase 2/3 Ready Drug Candidate Entering Trials 2H 2021
 
Palisade Bio (Nasdaq: PALI) is developing novel therapeutics designed to improve human health through therapeutic protection of the gastrointestinal (GI) mucosal barrier. PALI’s initial focus is combatting the interruption of GI function (ileus) following major surgery in order to accelerate recovery times and shorten the duration of patient hospital stays.
 
Watch Now
 
 
 
 
DeFi Technologies: Transforming the Global Financial System
 
Led by co-founders Wouter Witvoet and Olivier Roussy Newton, who collectively raised $1.4B in their prior two deals, DeFi Technologies (OTC: DEFTF) is well positioned to become a key player in the rapidly growing decentralized finance industry. The market size for the industry is measured in the trillions and spans multiple sectors, including insurance, derivatives, credit and lending, asset management, and exchanges.
 
Watch Now
 
 
 
 
Amesite: AI-Driven EdTech Transforming Learning
 
Amesite (Nasdaq: AMST) is an ed-tech, SaaS company with the most advanced artificial intelligence driven online learning platform in the industry, providing both content creation and a best-in-class infrastructure for the multi-billion-dollar online learning markets in business and education. The Company leverages existing institutional infrastructures, adding mass customization and cutting-edge technology to provide cost-effective, scalable, and engaging experiences for learners anywhere.
 
Watch Now
 
 
 
 
CBD of Denver Interviewed on Benzinga’s Cannabis Insider
 
CBD of Denver (CBDD) is a full-line CBD and hemp oil company, producing and distributing cannabis and CBD products in Switzerland, Europe, and the US. CBDD is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for its shareholders and is driven by a passion to improve lives and strengthen communities by unleashing the full potential of cannabis.
 
Watch Now
 
 
 
 
Tiziana Life Sciences: Robust Pipeline with Multiple Near-Term Catalysts
 
Tiziana Life Sciences (NASDAQ: TLSA) has developed proprietary oral, nasal, and inhaled formulation technologies that could transform immunotherapies with Monoclonal Antibodies currently administered intravenously for multiple indications.
 
Watch Now
 
 
 
 
Medalist Diversified REIT: Targeting Attractive Opportunities in Secondary Markets in Southeast U.S.
 
Medalist Diversified REIT (NASDAQ: MDRR) was founded in 2003 as a private equity company specializing in acquiring, owning, and managing commercial real estate in the Southeast. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns. Medalist utilizes a rigorous, consistent, and replicable process for sourcing and conducting due diligence of acquisitions.
 
Watch Now
 
 
 
 
Recruiter.com: Transforming the World of Recruiting
 
Recruiter.com (OTCQB: RCRT) is a hiring platform for the world’s largest network of recruiters. Recruiter.com empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology. The Recruiter.com network of over 28,000 small and independent recruiters utilize an innovative web platform, complete with AI-driven job matching, screening and video interviewing to recruit talent faster.
 
Watch Now
 
 
 
 
Virios Therapeutics: Potential Treatment Paradigm Shift for Fibromyalgia
 
Virios Therapeutics (Nasdaq: VIRI) is a clinical-stage biotechnology company focused on advancing novel, dual mechanism antiviral therapies to treat conditions associated with virally triggered or maintained immune responses, such as Fibromyalgia (“FM”).
 
Watch Now
 
 
 
 
Aptorum Group: Developing Novel Therapeutics for Unmet Medical Needs
 
Aptorum Group Limited (NASDAQ: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum's current drug pipeline includes indications in orphan diseases, infectious diseases, and metabolic diseases.
 
Watch Now
 
 
 
 
EVmo: Leading Provider of Rental Vehicles for the Gig Economy
 
EVmo (OTC: YAYO) bridges the gap between rideshare drivers in need of a suitable vehicle and rideshare companies that depend on attracting and keeping drivers. EVmo uniquely supports drivers in both the higher and lower economic categories with innovative policies and programs. EVmo is a leading provider of rental vehicles to drivers in the ever-expanding gig economy.
 
Watch Now
 
 
 
 
Killi: Transforming the $247B Market for Personal Data
 
Founded in 2018 and with offices in New York & Toronto, Killi (TSXV: MYID; OTCQB: MYIDD) is a company driven by the evolution of data and privacy. Killi aims to democratize data for consumers by providing them with an ecosystem where they can view, edit, opt-out, and be compensated for the use of their data. Today there is no destination for consumers to participate in the use of their data. Killi aspires to be the destination that consumers visit to reclaim control of their online data.
 
Watch Now
 
 
 
 
BTCS: Pioneer in Blockchain Space
 
BTCS Inc. (OTCQB: BTCS) is an early entrant in the digital asset market and one of the first U.S. publicly traded companies focused on digital assets and blockchain technologies. BTCS resumed its transaction verification services business segment in the first quarter of 2021 with a focus on validating transactions and operating nodes on proof-of-stake blockchains.
 
Watch Now
 
 
 
 
Learn Why Robert Blair, The Visionary Architect Behind Lulu Lemon (LULU) Joined RYU Apparel
 
RYU Apparel (OTCQB: RYPPF), or Respect Your Universe, is an award winning urban athletic apparel brand that engages in the development, marketing, and distribution of apparel, bags and accessories. Our products are engineered for the fitness, training and performance of the multi-discipline athlete. Our products are designed, developed and tested at our corporate headquarters in Vancouver, BC, Canada. Production takes place in factories located in North America and Asia.
 
Watch Now
 
 
 
 
Lantern Pharma: Transforming Cancer Drug Development with A.I.
 
Lantern Pharma (Nasdaq: LTNR) is a clinical stage biotechnology company leveraging its RADR® artificial intelligence (“A.I.”) platform to transform the pace, risk and cost of oncology drug development. RADR® A.I. quickly and efficiently develops precise genetic signatures of disease that underpin the identification of patients for whom its portfolio of oncology drug candidates is likely to have the greatest therapeutic effect. Lantern is currently developing three drug candidates in solid tumors.
 
Watch Now
 
 
 
 
Kiromic BioPharma: AI-Driven Immuno-Oncology Therapy Development
 
Kiromic BioPharma (Nasdaq: KRBP) is revolutionizing next-generation allogenic CAR therapies for solid tumors. The Company’s proprietary target discovery engine, Diamond uses AI and a proprietary neural network to identify development targets, dramatically compressing man years and billions of drug development dollars required to develop new live drugs.
 
Watch Now
 
 
 
 
Aridis Pharmaceuticals: Developing Novel Anti-Infective Therapies
 
Aridis Pharmaceuticals (Nasdaq: ARDS) discovers and develops anti-infectives to be used as add-on treatments to standard-of-care antibiotics. The Company is utilizing its proprietary ʎPEXTM and MabIgX® technology platforms to rapidly identify rare, potent antibody-producing B-cells from patients who have successfully overcome an infection, and to rapidly manufacture monoclonal antibody (mAbs) for therapeutic treatment of critical infections.
 
Watch Now
 
 
`
 
 
Hoth Therapeutics: Developing a New Generation of Therapies for Unmet Medical Needs
 
Hoth Therapeutics (Nasdaq: HOTH) is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. Hoth's clinical pipeline is concentrated on drug candidates that improve the quality of life for patients suffering from indications including atopic dermatitis, skin toxicities associated with cancer therapy, chronic wounds, psoriasis, asthma, acne, mast-cell derived cancers & anaphylaxis and pneumonia.
 
Watch Now
 
 
 
 
Order Small Stocks, Big Money Today!
 
Dave Gentry is the author of Small Stocks, Big Money: Interviews With Microcap Superstars. Published by Wiley, this first-hand perspective on the fast world of microcap investing is now available for purchase.
 
 
MidSouth Week in Review
 
Jobless claims hit a pandemic low of 444,000 vs. 481,000 the previous week.
Read More
 
 
 
 
About RedChip
 
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
 
RedChip Disclosure
 
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures.
 
 
     
 
 
Copyright © 2021 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.